Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 3/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 1/20 | 0.51 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.49 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.49 |
| ▸ | ESR1 | P03372 | 3/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.45 |
| ▸ | ERN1 | O75460 | 3/20 | 0.44 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.40 |
| ▸ | RELA | Q04206 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12249572 | 0.95 | APP (0.57) | APPCA1CA2CA9HSD17B1 | |
| SCHEMBL24083318 | 0.94 | APP (0.53) | APPCA1CA2CA9HSD17B1 | |
| SCHEMBL27451546 | 0.87 | APP (0.62) | APPCA1CA2CA9HSD17B1 | |
| SCHEMBL13843575 | 0.87 | APP (0.62) | APPCA1CA2CA9HSD17B1 | |
| SCHEMBL14178329 | 0.87 | APP (0.62) | APPCA1CA2CA9HSD17B1 | |
| SCHEMBL14178304 | 0.87 | APP (0.62) | APPCA1CA2CA9HSD17B1 | |
| SCHEMBL13843465 | 0.85 | APP (0.60) | APPCA1CA2CA9HSD17B1 | |
| SCHEMBL13843574 | 0.85 | APP (0.60) | APPCA1CA2CA9HSD17B1 | |
| SCHEMBL13843470 | 0.85 | APP (0.60) | APPCA1CA2CA9HSD17B1 | |
| SCHEMBL14178307 | 0.85 | APP (0.60) | APPCA1CA2CA9HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2588527-B1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL IND LTD (JP) | 2017-10-25 | — | — | EP | disclosed |
| US-20170186953-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170186953-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-9577194-B2 | Hole transport compositions and related devices and methods (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-02-21 | — | — | US | disclosed |
| US-9577194-B2 | Hole transport compositions and related devices and methods (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-02-21 | — | — | US | disclosed |
| US-9112157-B2 | Hole transport materials including OLED applications | SOLVAY USA, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-8815639-B2 | Hole transport compositions and related devices and methods (II) | SOLVAY USA, INC. (US) | 2014-08-26 | — | — | US | disclosed |
| US-8815639-B2 | Hole transport compositions and related devices and methods (II) | SOLVAY USA, INC. (US) | 2014-08-26 | — | — | US | disclosed |
| US-8535974-B2 | Hole transport compositions and related devices and methods (II) | PLEXTRONICS, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| US-8535974-B2 | Hole transport compositions and related devices and methods (II) | PLEXTRONICS, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| US-20120001127-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120003790-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AMD METHODS (II) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120003790-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AMD METHODS (II) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120001127-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| WO-2012003482-A2 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (II) | PLEXTRONICS, INC. (US) | 2012-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120001127-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | OCIAD2, OCIAD1, SLCO1B1 | APP 1121/4885CA1 4761/4885CA2 4672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.